Cargando…
Aripiprazole lai two-injection start in a 16 year-old with Schizophrenia
INTRODUCTION: Aripiprazole LAI is approved for the treatment of schizophrenia in adults. Recently, Europe and Canada approved the use of the two-injection start (TIS) regimen: two separate injections of 400 mg long-acting aripiprazole along with a single 20 mg dose of oral aripiprazole. Aripiprazole...
Autores principales: | Marpepa, B., Appignanesi, C., Orsolini, L., Volpe, U., Salvi, V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568000/ http://dx.doi.org/10.1192/j.eurpsy.2022.2058 |
Ejemplares similares
-
Aripiprazole LAI two‐injection start in a 16 year‐old adolescent with schizophrenia
por: Salvi, Virginio, et al.
Publicado: (2022) -
Efficacy and tolerability Aripiprazole once-monthly long-acting injectable in schizophrenia. Two-injection start regimen
por: Romero Guillena, S.L., et al.
Publicado: (2022) -
Effects of aripiprazole long-acting two-injection start in patients diagnosed with schizophrenia in Huelva (Spain)
por: Moleon, A., et al.
Publicado: (2023) -
Clozapine-Treatment-Resistant Schizophrenia Successfully Managed with Brexpiprazole Combination Therapy: Two Case Reports
por: Orsolini, L., et al.
Publicado: (2022) -
An observational naturalistic study on non-suicidal self-harm behaviours in a cohort of adolescents and young inpatients during COVID-19 outbreak
por: Orsolini, L., et al.
Publicado: (2022)